Back to VA VANGUARD CAPITAL MANAGEMENT LLC
PCVX2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in VAXCYTE INC
Yes. Vanguard Capital Management holds 6,348,679 shares of PCVX (Vaxcyte), worth $369M, as of its Q2 2026 13F filing. It increased the position by 81,978 shares (+1.3%) from Q1 2026. Vanguard Capital Management has held PCVX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$369M
Current Shares
6.3M
Total Value Change
+$4.9M
Total Shares Change
+81,978
Quarter-by-Quarter History
Other major holders of PCVX: FMR LLC, VANGUARD GROUP INC, Janus Henderson Group Ltd., BlackRock, Inc.